Corbus Pharmaceuticals Holdings (CRBP) Asset Utilization Ratio (2015 - 2022)
Corbus Pharmaceuticals Holdings (CRBP) recorded quarterly Asset Utilization Ratio of 0.0 in Q2 2022, down 52.38% quarter-over-quarter from 0.0 in Q1 2022, and down 96.18% on a YoY basis from 0.03 in Q2 2021.
Corbus Pharmaceuticals Holdings (CRBP) Asset Utilization Ratio (2015 - 2022) Analysis & Trends
Corbus Pharmaceuticals Holdings' Asset Utilization Ratio history runs 8 years deep, the most recent figure standing at 0.0 for Q2 2022.
- In Q2 2022, Asset Utilization Ratio fell 96.18% year-over-year to 0.0; the TTM figure through Jun 2022 stood at 0.0 (down 96.18% YoY), while the FY2021 annual figure was 0.01, down 87.29% from the prior year.
- Asset Utilization Ratio was 0.0 for Q2 2022 at Corbus Pharmaceuticals Holdings, down from 0.0 in the prior quarter.
- In the past five years, Asset Utilization Ratio ranged from a high of 0.44 in Q3 2019 to a low of 0.29 in Q2 2020.
- Historically, Asset Utilization Ratio has averaged 0.04 across 5 years, with a median of 0.03 in 2018.
- The sharpest annual moves came in 2019 and 2020: Asset Utilization Ratio jumped 907.31% in 2019, then plunged 184.23% in 2020.
- A 5-year view of Asset Utilization Ratio shows it stood at 0.06 in 2018, then surged by 48.97% to 0.09 in 2019, then plunged by 40.81% to 0.05 in 2020, then sank by 84.63% to 0.01 in 2021, then sank by 85.88% to 0.0 in 2022.
- The last three Asset Utilization Ratio figures came in at 0.0 (Q2 2022), 0.0 (Q1 2022), and 0.01 (Q4 2021), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | 0.55 |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | 0.60 |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | 1,422.00 |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 0.47 |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | - |
| 10 | Corbus Pharmaceuticals Holdings | 133.67 Mn | 105.86 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2022 | 0.00 |
| Mar 31, 2022 | 0.00 |
| Dec 31, 2021 | 0.01 |
| Sep 30, 2021 | 0.02 |
| Jun 30, 2021 | 0.03 |
| Mar 31, 2021 | 0.03 |
| Dec 31, 2020 | 0.05 |
| Sep 30, 2020 | -0.26 |
| Jun 30, 2020 | -0.29 |
| Mar 31, 2020 | 0.09 |
| Dec 31, 2019 | 0.09 |
| Sep 30, 2019 | 0.44 |
| Jun 30, 2019 | 0.35 |
| Mar 31, 2019 | 0.05 |
| Dec 31, 2018 | 0.06 |
| Sep 30, 2018 | 0.04 |
| Jun 30, 2018 | 0.04 |
| Mar 31, 2018 | 0.03 |
| Dec 31, 2017 | 0.05 |
| Sep 30, 2017 | 0.08 |